🚀 Exciting announcement! ⭐️ Join us at #BAUS25 for our special session on Monday, 16 June! 🕓 16:30 - 16:45 📍 Charter 3 📢 We are thrilled to welcome our keynote speaker, Freddie Hamdy, who will discuss, "The Challenge of Misinformation"! #BURSTatBAUS #UroSoMe @bausurology.bsky.social

An important (very short) film from Steve McQueen - don’t be embarrassed to talk about #ProstateCancer. Can effect all men but there’s a higher risk for black men. www.embarrassedfilm.org It’ll take less than 2 mins of your time to watch. An inspiring talk at #BAUS25

Inaccuracy of rapid at home PSA tests www.bbc.co.uk/news/article...

Prostate cancer: Rapid at-home PSA tests spark concerns

Testing for PSA protein can indicate whether a man is at risk of prostate cancer.

bbc.co.uk

Woohoo! Great work team @jimcatto.bsky.social bmjopen.bmj.com/content/bmjo...

www.sheffield.ac.uk/news/thousan...

Thousands of men in Yorkshire to take part in new prostate screening trial

​​​​​​​Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial led by the University of Sheffield.

sheffield.ac.uk

www.yorkshirecancerresearch.org.uk/news/thousan...

Thousands of men in Yorkshire to take part in new prostate screening trial - Yorkshire Cancer Research

Thousands of men in Yorkshire will be offered the opportunity to take part in a new £4.5 million prostate screening trial funded by Yorkshire Cancer Research.

yorkshirecancerresearch.org.uk

🏃 Flying start to #IP9ATLAS - first 5️⃣0️⃣ patients recruited! 🔎 Comparing regular MRI scans to standard of care in patients with prostate cancer on active surveillance 🎉 Thank you to our site teams Imperial College Healthcare NHST, Dartford and Gravesham NHST & Frimley Health NHSFT

Can mpMRI replace TURBT for faster treatment in MIBC? A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social ascopubs.org/doi/10.1200/JC…

Great to see this finally out #bladdercancer ascopubs.org/doi/10.1200/...

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial

PURPOSETransurethral resection of bladder tumor (TURBT) is the initial staging procedure for new bladder cancers (BCs). For muscle-invasive bladder cancers (MIBCs), TURBT may delay definitive treatmen...

ascopubs.org

Now published: This MA is the basis for our ongoing #ZMoveMent1 study evaluating the impact of endurance*resistance training on QoL, oncological outcomes, fitness in #ProstateCancee pts 👉 we still don’t use #PhysicalExercise in cancer pts in an optimal way 👉 www.mdpi.com/2072-6694/16...

The Effect of Resistance and/or Aerobic Training on Quality of Life, Fitness, and Body Composition in Prostate Cancer Patients—A Systematic Review and Meta-Analysis

Background: Prostate cancer (PC) and its treatment are often associated with side effects such as fatigue, muscle loss, and diminished quality of life (QoL). Physical exercise, particularly resistance...

mdpi.com

Sabine D. Brookman-May, MD, FEBU🚴‍♀️🚴‍♀️🚴‍♀️🏔️⛷️⛰️@brookmans76.bsky.social · 2y ago

Exercise improves quality of life for #ProstateCancer patients. Our latest systematic review shows combined resistance and aerobic training reduces fatigue, enhances mental and sexual health, and boosts fitness. Resistance training also improves body composition #ProstateCancer #PhysicalExercise

www.sheffield.ac.uk/news/surviva...

Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery

​​​​​​​A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to b...

sheffield.ac.uk

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer oncodaily.com/insight/sasa... #BladderCancer #Cancer #EventFreeSurvival #EFS #OncoDaily #Oncology #Pfizer #Sasanlimab

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer - OncoDaily

Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer / bladder cancer, cancer, event-free survival (EFS), Neal Shore,

oncodaily.com

#CREST trial with positive results for #PD-1 in HR #NMIBC! ✅The study evaluated #sasanlimab (PD-1i)+BCG vs standard #BCG (induction + maintenance) in BCG-naïve, HR NMIBC. ✅The study met its primary endpoint with significant improvement of EFS pfizer.com/news/press-rel… @oncodaily.bsky.social

Key findings include an increase in men newly diagnosed with prostate cancer: in 2023 in England, a 9% increase when compared to 2022 and a 25% increase compared to 2019. In 2022 in Wales, a 26% increase compared to 2021.

Geographic patterns of #prostatecancer reflect awareness, mens health and PSA testing. Big differences exist in the UK and other countries @prostatecanceruk.bsky.social prostatecanceruk.org/about-us/new...

Huge North-South divide in prostate cancer diagnoses

We want to stop prostate cancer being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.

prostatecanceruk.org

Credit the authors ... its hard to find defendants of TRUS-Bx in an era of TREXIT. RCTs mostly show equivalence but fewer infections - see www.bmj.com/content/387/... There is loss of equipoise amongst urologists. Patient views under-represented. www.eu-focus.europeanurology.com/article/S240...

(Over)diagnosis of very low risk #prostatecancer in the USA. The disease that won't go away ..... despite MRI use. Time to abandon random biopsy @dr-coops.bsky.social euoncology.europeanurology.com/article/S258...

Nice. How to write a Response to reviewers. Amazing how many authors ignore simple questions. Reviewers are usually helping you improve your work. Well done @vickersbiostats.bsky.social @euplatinum.bsky.social www.europeanurology.com/article/S030...

1. HIFU vs Radical prostatectomy non-randomised comparison. Large 1,967 HIFU & 1,361 RP, contemporary 2015-19. 62% intermediate-risk PC. Similar adverse events except long term continence and erectile scores. Less salvage treatments with HIFU. www.europeanurology.com/article/S030...

I’ve just signed the @prostatecanceruk.bsky.social letter to the Secretary of State for Health and Social Care @rthonwesstreeting.bsky.social asking for simple and free changes to outdated #prostatecancer testing guidelines. Add your name now - it takes less than a minute!

Men are being left behind by outdated prostate cancer guidelines.

I’ve just signed Prostate Cancer UK’s letter to the Secretary of State for Health and Social Care so that we can improve the outcomes and experience for men in the UK with prostate cancer. Add your n...

campaigns.prostatecanceruk.org

Moving from the dance floor 🕺💃 to the balcony 🏛️” - Great leadership requires both action & reflection. Insightful session by @brookmans76.bsky.social at #EAUTalentIncubator on finding balance in leadership! 👏✨ @uroweb.bsky.social #LeadershipDevelopment

The National Prostate Cancer Audit State of the Nation Report 2024 has been published! It is available here www.npca.org.uk/reports/npca... alongside its appendix, methodology supplement and data tables.

In over 460,000 women throughout Germany, #AI second readings of mammograms led to improved breast cancer detection, a lower recall rate, and significantly reduced workload nature.com/articles/s41... open-access

Mosaic pattern loss of Y chromosome, which occurs in ~40% of men by age 70, is causally linked to heightened risk of many diseases, including cardiovascular, bladder cancer, and Alzheimer's. But it's almost never assessed clinically. A new review nature.com/articles/s41...

Bonus effect. When a drug for diabetes significantly reduces kidney stones, results of a randomized trial of empagliflozin (Jardiance), a SGLT-2 inhibitor, in people without diabetes www.nature.com/articles/s41...

“The drug is life-changing. To come out the other side with this extra treatment, it makes it easier to be hopeful and confident of being healthy.” Annie Baker was treated for #BreastCancer with olaparib – a drug developed following crucial involvement by ICR scientists.

Grateful every day to lead the incredible Fox Chase Urology team as we tackle the region’s toughest cases and push the boundaries of our field (like this week’s JCO pub: pubmed.ncbi.nlm.nih.gov/39680823/). Happy and healthy holiday season to all! www.foxchase.org/clinical-car...

Initial active surveillance and watchful waiting significantly increased for intermediate–risk prostate cancer between 2010 and 2020. https://ja.ma/4042hPZ

Congratulations #IP7PACIFIC - 8️⃣6️⃣5️⃣ patients recruited so far! ⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies to detect prostate cancer 🔗 imperial.ac.uk/news/233114/... 🎉 Thank you to all of our outstanding recruitment sites!

Genomic sequencing identified hereditary cancer risks in 9% of patients after uninformative gene panels. However, most findings lacked evidence-based guidelines. #Genomics #Cancer #Oncology @oncoalert.bsky.social @viveksubbiah.bsky.social @realbowtiedoc.bsky.social doi.org/10.1200/PO-2...